FK506 INHIBITS ANTI-IGM ANTIBODY-INDUCED APOPTOSIS AND 17KD ENDONUCLEASE ACTIVITY IN THE HUMAN B-CELL LINE, MBC-1, ESTABLISHED FROM BURKITTS-LYMPHOMA

Citation
M. Higashigawa et al., FK506 INHIBITS ANTI-IGM ANTIBODY-INDUCED APOPTOSIS AND 17KD ENDONUCLEASE ACTIVITY IN THE HUMAN B-CELL LINE, MBC-1, ESTABLISHED FROM BURKITTS-LYMPHOMA, British Journal of Haematology, 99(4), 1997, pp. 908-913
Citations number
25
ISSN journal
00071048
Volume
99
Issue
4
Year of publication
1997
Pages
908 - 913
Database
ISI
SICI code
0007-1048(1997)99:4<908:FIAAAA>2.0.ZU;2-G
Abstract
The endonuclease which causes antibody-induced apoptotic cell death in B cells is not completely understood. We previously established a B-c ell line (MBC-1) from a patient with Burkitt's lymphoma at the leukaem ic stage which demonstrated the typical morphology and internucleosoma l DNA fragmentation of apoptotic cell death when treated with anti-IgM antibody. FK506, an immunosuppressive agent and calcineurin inhibitor , partially rescued the anti-IgM antibody-induced cell death in these MBC-1 cells. DNA SDS-PAGE nuclease activity assay demonstrated that a 17 kD protein exhibited endonuclease activity. Active gel assay showed nuclease activity in the cellular nuclear extract not treated with an ti-IgM antibody. This nuclease activity was inhibited by FK506 at conc entrations of 10-200 ng/ml in the native gel assay. These results rais e the possibility that the 17 kD endonuclease is one of the nuclear me mbers of the immunophilin family, which may function as an endogenous endonuclease in MBC-1 cells.